The prevalence of rheumatic immune-related adverse events in 524 patients with cancer who received immune checkpoint inhibitors was 6.6%, according to a single-center observational study published in Annals of the Rheumatic Diseases.READ MORE
The potential impact of CAR-T therapies should not be underestimated, nor should their complexity, which is why a broader understanding of stakeholder knowledge and perception may be critical to their adoption and use. READ MORE
October 18-20 marked the annual Association of Community Cancer Centers (ACCC) National Oncology Conference. Key opinion leaders convened in Nashville, Tennessee to share cutting-edge ideas, strategies, and practical takeaways for transforming patient care in cancer programs. READ MORE
A recent study found which characteristic to be associated with survival in AML?